Infinium Global Research’s recent report on the “Tissue Diagnostics Market (By Product (Accessories, Instruments), By Technology (Digital Pathology and Workflow, Special Staining, In Situ Hybridization, and Immunohistochemistry (Ihc)), and by Application (Non-Small Cell Lung Cancer, Prostate Cancer, Gastric Cancer, Breast Cancer, Lymphoma) by End-User(Research Laboratories, Pharmaceutical Organizations, Contract Research Organization (CRO), Hospitals) Global Industry Analysis, Trends, Market Size & Forecasts to 2030” provides a comprehensive outline of the factors responsible for the growth of the market.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/947
"We are Now Including the Impact Analysis of COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2023-2030."
The Section on the Impact of COVID-19 on this Market is Included in the Report for Free.
Tissue diagnostics involves the removal of tissue from the patient’s body, which is then processed, analyzed, and tested under the microscope to detect diseases such as cancer. The Advancements in techniques and equipment of tissue diagnostics help for fast and accurate determination and evaluation of diseases related to the tissues. Tissues are generally aided for personalized diagnosis & treatment and the samples obtained usually consist of pieces of tissue attained by various methods, which include small biopsies and large specimens removed at surgery. The major factors such as increasing healthcare expenditure and technological advancements in tissue diagnostics drive the growth of the tissue diagnostics market in the upcoming years.
The sudden occurrence of the covid19 pandemic caused an increase in diagnostics activities, treatment, and procedures, and a rise in R&D activities to develop diagnostics such as molecular tests. The growing demand during the covid 19 pandemic for diagnostics procedures and products created lucrative opportunities in the healthcare industry.
The Breast Segment Dominates the Tissue Diagnostics Market
The breast cancer segment accounted for the largest share in terms of revenue in 2020 owing to high occurrence rates of breast cancer globally, caused due to increase in inheritance and family history. Furthermore, several research initiatives coupled with the support of the government and private centers, drive the development of effective products for the diagnosis of breast cancer. The presence of several public programs aiming to minimalize cancer incidence and the rising demand for cancer diagnosis supplements. This has augmented the revenue generation for this segment.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/947
The North American Region is to Be Expected the Fastest-growing Region in Tissue Diagnostics Market
In terms of region, North America generated the largest revenue in the global Tissue Diagnostics Market in 2020 and is expected to remain the leading market over the forecast years. Due to the presence of key market players and rising technological advancements in the healthcare sector in this region. Moreover, the increasing healthcare expenditure and high-quality infrastructure for hospitals and clinical laboratories in this region are the major factors driving the growth of the Tissue Diagnostics Market in the North American region.
Furthermore, the Asia Pacific region is expected to grow at the fastest rate in the Tissue Diagnostics Market over the forecast period. The convenience of technically advanced cancer diagnostic techniques, increasing healthcare expenditure, and government funding for the development and launch of advanced diagnostic platforms would complement regional growth.
Key Players Focus to Increase the Production Capacity by Collaborating with Other Companies
The Tissue Diagnostics Market is intensely competitive with the presence of several multinational and local players. The major players are Prometheus Laboratories, Roche, DiaGenic, Abbott, Becton Dickinson & Company, Qiagen, Siemens Healthcare, Johnson & Johnson, GE Healthcare, and Bio SB. and several others are constantly focusing on developing new products and services to gain a competitive edge in the market. These companies are adopting numerous market strategies including new product launches, collaboration, and mergers & acquisitions with numerous other companies at the country level.
For instance, in January 2021, Roche launches two digital pathology image analysis algorithms for the precision patient diagnosis of breast cancer. Infinium Global Research’s recent report on the global Tissue Diagnostics Market is an encompassment of such recent developments in the global marketplace. The report delivers insights into the recent developments by leading players that have contributed to the growth of the Tissue Diagnostics Market and also estimates the impact of recent developments in the global market.
More Insights on This Report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/947
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of tissue diagnostic.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
No comments:
Post a Comment